N. Balandraud

发表

Autoantibodies to PAD4 and BRAF in rheumatoid arthritis.

I. Auger, C. Charpin, N. Balandraud, 2012, Autoimmunity reviews.

Antinuclear Antibodies in Patients with Psoriatic Arthritis Treated or Not with Biologics

I. Auger, N. Balandraud, J. Roudier, 2015, PloS one.

Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3-year prospective study in France.

X. Mariette, J. Sibilia, N. Balandraud, 2002, Blood.

Anti-Ephrin Type-B Receptor 2 (EphB2) and Anti-Three Prime Histone mRNA EXonuclease 1 (THEX1) Autoantibodies in Scleroderma and Lupus

L. Chiche, T. Martin, E. Hachulla, 2016, PloS one.

A rigorous method for multigenic families' functional annotation: the peptidyl arginine deiminase (PADs) proteins family example

P. Pontarotti, N. Balandraud, J. Roudier, 2005, BMC Genomics.

3-year prospective study in France Lymphomas in rheumatoid arthritis patients treated with methotrexate: a

X. Mariette, N. Balandraud, D. Cazals‐Hatem, 2013 .

Leveraging whole blood based functional flow cytometry assays to open new perspectives for rheumatoid arthritis translational research

N. Balandraud, J. Roudier, P. Lafforgue, 2022, Scientific Reports.

New autoantibodies in early rheumatoid arthritis

I. Auger, C. Charpin, N. Balandraud, 2013, Arthritis Research & Therapy.

What are the links between Epstein-Barr virus, lymphoma, and tumor necrosis factor antagonism in rheumatoid arthritis?

N. Balandraud, J. Roudier, C. Roudier, 2005, Seminars in arthritis and rheumatism.

Rheumatoid arthritis-specific autoantibodies to peptidyl arginine deiminase type 4 inhibit citrullination of fibrinogen.

I. Auger, N. Balandraud, Marielle Martin, 2010, Arthritis and rheumatism.

Polymorphism at the position -308 of TNF-α gene influences outcome of infliximab therapy in rheumatoid arthritis

N. Balandraud, J. Roudier, B. Mugnier, 2004, Arthritis Research & Therapy.

Autoantibodies to BRAF, a new family of autoantibodies associated with rheumatoid arthritis

I. Auger, C. Charpin, N. Balandraud, 2010, Arthritis Research & Therapy.

Safety of TNF-blocking agents in rheumatic patients with serology suggesting past hepatitis B state: results from a cohort of 21 patients

C. Charpin, N. Balandraud, J. Roudier, 2009, Arthritis research & therapy.

Cutaneous pseudolymphoma associated with a TNF-alpha inhibitor treatment: etanercept.

N. Balandraud, J. Roudier, J. Mattei, 2008, European journal of dermatology : EJD.

The shared epitope revisited: shared epitope negative HLA-DR alleles influence susceptibility to rheumatoid arthritis

P. Tiberghien, N. Balandraud, J. Roudier, 2001, Arthritis Research.

Long-term treatment with methotrexate or tumor necrosis factor alpha inhibitors does not increase epstein-barr virus load in patients with rheumatoid arthritis.

J. Meynard, I. Auger, N. Balandraud, 2007, Arthritis and rheumatism.

Association study between HLA-A, -B, -C, -DRB1 alleles and Psoriatic arthritis in southern France.

N. Balandraud, Marielle Martin, J. Roudier, 2022, Human immunology.

Microchimerism of the shared epitope in rheumatoid arthritis. Authors' reply

I. Auger, N. Balandraud, Marielle Martin, 2009 .

Is self-assessment by patients of disease activity acceptable over the long term in rheumatoid arthritis? A 3-year follow-up of 771 patients.

M. Dougados, X. Mariette, L. Gossec, 2019, Rheumatology.

Biomarkers in psoriatic arthritis: A meta-analysis and systematic review

L. Boyer, N. Balandraud, P. Lafforgue, 2022, Frontiers in Immunology.

TWEAK-binding autoantibodies are generated during psoriatic arthritis and are not influenced by anti-TNF therapy

P. Berbis, N. Balandraud, D. Stephan, 2016, Journal of Translational Medicine.

Functional categorization of HLA-DRB1 alleles in rheumatoid arthritis: the protective effect.

N. Balandraud, J. Roudier, M. Touinssi, 2003, Human immunology.

Influence of shared epitope-negative HLA-DRB1 alleles on genetic susceptibility to rheumatoid arthritis.

P. Tiberghien, N. Balandraud, J. Roudier, 2001, Arthritis and rheumatism.

Epstein-Barr virus and rheumatoid arthritis.

N. Balandraud, J. Roudier, 2017, Joint, bone, spine : revue du rhumatisme.

Epstein-Barr virus and rheumatoid arthritis.

N. Balandraud, J. Roudier, C. Roudier, 2004, Autoimmunity reviews.

COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study

Julie M. Woessner, P. Hennequin, Cécile Paris, 2021, The Lancet Rheumatology.

How microchimerism can impart HLA susceptibility in patients with rheumatoid arthritis

I. Auger, N. Balandraud, Marielle Martin, 2010, Chimerism.

Epstein-Barr virus load in the peripheral blood of patients with rheumatoid arthritis: accurate quantification using real-time polymerase chain reaction.

Nathalie Balandraud, J. Meynard, I. Auger, 2003, Arthritis and rheumatism.

FIGENIX: Intelligent automation of genomic annotation: expertise integration in a new software platform

André Gilles, Pierre Pontarotti, Etienne G. J. Danchin, 2005, BMC Bioinformatics.

Evaluation of X Chromosome Inactivation with Respect to HLA Genetic Susceptibility in Rheumatoid Arthritis and Systemic Sclerosis

T. Ozcelik, I. Auger, N. Balandraud, 2016, PloS one.

Peptidyl arginine deiminase immunization induces anticitrullinated protein antibodies in mice with particular MHC types

I. Auger, N. Balandraud, J. Roudier, 2017, Proceedings of the National Academy of Sciences.

Mosaicism of XX and XXY cells accounts for high copy number of Toll like Receptor 7 and8 genes in peripheral blood of men with Rheumatoid Arthritis

I. Auger, N. Balandraud, Marielle Martin, 2019, Scientific Reports.

Long‐term treatment with methotrexate or tumor necrosis factor α inhibitors does not increase epstein‐barr virus load in patients with rheumatoid arthritis

J. Meynard, I. Auger, N. Balandraud, 2007 .

COVID-19 presentation and outcomes in patients with inflammatory rheumatic and musculoskeletal diseases receiving IL6-receptor antagonists prior to SARS-CoV-2 infection

E. Hachulla, J. Avouac, É. Drumez, 2023, Journal of Translational Autoimmunity.

HLA-DRB1 Genotypes and the Risk of Developing Anti Citrullinated Protein Antibody (ACPA) Positive Rheumatoid Arthritis

É. Pardoux, I. Auger, C. Charpin, 2013, PloS one.

In Rheumatoid Arthritis Patients, HLA-DRB1*04:01 and Rheumatoid Nodules Are Associated With ACPA to a Particular Fibrin Epitope

G. Serre, I. Auger, N. Balandraud, 2021, Frontiers in Immunology.

Peptidylarginine Deiminase Autoimmunity and the Development of Anti–Citrullinated Protein Antibody in Rheumatoid Arthritis: The Hapten–Carrier Model

I. Auger, N. Balandraud, Marielle Martin, 2019, Arthritis & rheumatology.

Influence of HLA-DR genes on the production of rheumatoid arthritis-specific autoantibodies to citrullinated fibrinogen.

M. Sebbag, C. Vincent, G. Serre, 2005, Arthritis and rheumatism.

A complete phylogenetic analysis coupling expression data from EST databases. An example with a family of genes: the peptidyl arginine deiminase genes

P. Pontarotti, N. Balandraud, P. Gouret, 2005, Arthritis Research & Therapy.

Long term treatment with abatacept or tocilizumab does not increase Epstein-Barr virus load in patients with rheumatoid arthritis - A three years retrospective study

I. Auger, N. Balandraud, Marielle Martin, 2017, PloS one.

First flare of ACPA-positive rheumatoid arthritis after SARS-CoV-2 infection

N. Balandraud, J. Roudier, C. Zandotti, 2020, The Lancet Rheumatology.

Newly Identified BRAF Mutation in Rheumatoid Arthritis

L. Ouafik, I. Auger, N. Balandraud, 2016, Arthritis & rheumatology.

HLA-DRB1*0404 is strongly associated with high titers of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis.

I. Auger, C. Charpin, N. Balandraud, 2008, Clinical and experimental rheumatology.

TMEM187-IRAK1 Polymorphisms Associated with Rheumatoid Arthritis Susceptibility in Tunisian and French Female Populations: Influence of Geographic Origin

É. Pardoux, G. Lefranc, I. Touitou, 2017, Journal of immunology research.

Influence of -308 A/G polymorphism in the tumor necrosis factor alpha gene on etanercept treatment in rheumatoid arthritis.

Olfert Landt, Jean-Pierre Mattei, Julien Bouvenot, 2007, Arthritis and rheumatism.

Polymorphism at position -308 of the tumor necrosis factor alpha gene influences outcome of infliximab therapy in rheumatoid arthritis.

Nathalie Balandraud, N. Balandraud, J. Roudier, 2003, Arthritis and rheumatism.

New autoantigens in rheumatoid arthritis (RA): screening 8268 protein arrays with sera from patients with RA

I. Auger, N. Balandraud, Marielle Martin, 2008, Annals of the rheumatic diseases.

How RA Associated HLA-DR Molecules Contribute to the Development of Antibodies to Citrullinated Proteins: The Hapten Carrier Model

I. Auger, N. Balandraud, J. Roudier, 2022, Frontiers in Immunology.

Do RA associated HLA-DR molecules bind citrullinated peptides or peptides from PAD4 to help the development of RA specific antibodies to citrullinated proteins?

I. Auger, N. Balandraud, J. Roudier, 2020, Journal of autoimmunity.

Diagnostic contribution of HLA-A,B,C,DR genotyping in inflammatory joint disease.

N. Balandraud, J. Roudier, E. Massy, 2018, Joint, bone, spine : revue du rhumatisme.

Transfer of the shared epitope through microchimerism in women with rheumatoid arthritis.

I. Auger, N. Balandraud, Marielle Martin, 2009, Arthritis and rheumatism.

Patients with ankylosing spondylitis have been breast fed less often than healthy controls: a case–control retrospective study

M. Breban, N. Balandraud, J. Roudier, 2015, Annals of the rheumatic diseases.

AB0233 Diagnosis and Evolution of Anti-Citrullinated Peptide Antibody (ACPA)-Negative Rheumatoid Arthritis (RA) Patients: A Retrospective Study of 48 Patients

N. Balandraud, J. Roudier, P. Carli, 2014 .

HLA-DRB1 polymorphism, anti-citrullinated protein antibodies, and rheumatoid arthritis

I. Auger, N. Balandraud, J. Roudier, 2018, The Journal of Biological Chemistry.

HLA-DRB1*0404 is strongly associated with anticalpastatin antibodies in rheumatoid arthritis

I. Auger, N. Balandraud, J. Roudier, 2007, Annals of the rheumatic diseases.

The learning curve of nurses for the assessment of swollen and tender joints in rheumatoid arthritis.

M. Dougados, L. Gossec, N. Balandraud, 2014, Joint, bone, spine : revue du rhumatisme.

Atypical Mycobacterium marinum infection (Aquarium granuloma) in a patient on TNFα antagonist therapy for psoriatic arthritis.

N. Balandraud, J. Roudier, E. Poisnel, 2014, Joint, bone, spine : revue du rhumatisme.

A rigorous method for multigenic families' functional annotation: the peptidyl arginine deiminase (PADs) proteins family example

N. Balandraud, Etienne G. J. Danchin, Philippe Gouret, 2005, BMC Genomics.

anticalpastatin antibodies in rheumatoid arthritis HLA-DRB1*0404 is strongly associated with

I. Auger, N. Balandraud, S. Guis, 2008 .

Autoantibodies to PAD4 and BRAF in rheumatoid arthritis.

I. Auger, C. Charpin, N. Balandraud, 2012, Autoimmunity reviews.

Improving agreement in assessment of synovitis in rheumatoid arthritis.

M. Dougados, L. Gossec, N. Balandraud, 2013, Joint, bone, spine : revue du rhumatisme.